Market Forecast News

Tuesday, 6 March 2018

Future Business Opportunities in Dietary Supplements Market

The global dietary supplements market is expected to reach USD 278.02 billion by 2024, at a CAGR of 9.6% from 2016 to 2024, according to a report by Grand View Research, Inc. Rising obesity rates in developed economies including the U.S. and Germany as a result of fluctuating dieting patterns along hectic work style among adults is expected to prompt the spending on nutritional supplements.

Over the past few years, the high adoption rate of fast foods along sedentary lifestyle in emerging economies including China and India has led to the increase in the prevalence of cardiovascular disorders, diabetes, and obesity. As a result, the individuals among high socio-economic and upper-middle-class income groups are expected to perceive the nutraceuticals including dietary supplements as the alternatives to prescribed drugs.

Vitamin supplements market revenue was more than USD 50 billion in 2015. Rising application of sports-related supplements for old-aged groups coupled with targeting the supplements against muscle wastage and maintenance of healthy joints is expected to have a strong impact on vitamin ingredient category in the near future.

To request a sample copy or view summary of this report:
https://www.grandviewresearch.com/industry-analysis/dietary-supplements-market

Further key findings from the report suggest:

Tablets are projected to generate a revenue of exceeding USD 100 billion by the end of 2025. Increased prevalence of multivitamin products in the form of tablets on account of comfortable dosage patterns is projected to have a substantial impact over the next eight years.
Pregnant women segment reported a revenue of USD 12.55 billion in 2015. Rising importance of folic acid based nutraceuticals for fetal development during the initial stage of pregnancy is projected be a key market trend.
Asia Pacific is expected to foresee the fastest growth at a CAGR of 11.2% from the period of 2016 to 2024. The strong foothold of middle-class income groups in China, India, Bangladesh, Pakistan, and Thailand is expected to force the nutraceuticals manufacturers to invest in the above-mentioned countries.
Key manufacturers dominating the Dietary Supplement market are Amway, Archer Daniels Midland Company, Abbott Laboratories, Bayer, Glanbia, Arkopharma Laboratories Pharmaceuticals, Glaxo SmithKline. Strengthening product length and capital expansion are expected to remain a key critical success factor for the industry for coming years.
In February 2016, NBTY, Inc., agreed to sell Vitamin World, a U.S retail business to Centre Lane Partners. This agreement is a standalone business with investment and resources tailored to retail business operations. This strategy is expected to benefit the company to position itself in the market with long-term growth and success.

Access press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-dietary-supplements-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Rapid Increase in Vaccine Contract Manufacturing Market - Key Factors, Market Segments Regions & Industry Forecasts Analysis to 2025

The global vaccine contract manufacturing market size is expected to reach USD 4.0 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a 9.3% CAGR during the forecast period. The market is anticipated to witness significant growth over the coming years thanks to rising demand for vaccine development from the private sector as well as governments in industrialized and developing countries.

Vaccine contract services offer cost-saving benefits to their clients. They also help save time in operations and management of a production and research facility. These advantages associated with Contract Manufacturing Organizations (CMOs) are expected to benefit emerging players, start-ups, and small players who lack adequate facilities and resources required for vaccine development.

Increase in pricing pressure, regulatory challenges, and patent expiration in recent times are expected to adversely impact the market. Contract services are considered “strategic competitive weapons” among vaccine manufacturers as they help overcome the aforementioned issues.

A number of international healthcare organizations are engaged in estimating and predicting the quantity of goods as well as financial need required for conducting immunization programs. Some of the factors considered for this estimation are quantity of vaccines, estimated time of delivery, product type, and vial size. Participation of international healthcare organizations in vaccination programs is expected to positively influence the growth of contract manufacturers.

To request a sample copy or view summary of this report:
https://www.grandviewresearch.com/industry-analysis/vaccine-contract-manufacturing-market

Further key findings from the report suggest:

Contract services for development of attenuated vaccines accounted for the major share in the market based on vaccine type. This can be attributed to the fact that these vaccines offer immunity for a lifetime with only one or two doses
DNA vaccines form the fastest-growing segment by type, with several kinds already being tested on humans
Based on workflow, downstream processing dominated the market mainly due to the necessity of mature and reliable biotechnology tools for product recovery. Various research initiatives in the space are also contributing in advancing downstream workflows
By application, contract services for the development of human-use vaccines held the largest share owing to their high adoption to develop vaccines against influenza and other illnesses
Lonza; IDT Biologika GmbH; FUJIFILM Diosynth Biotechnologies U.S.A., Inc.; and Merck KGaA are some of the major players offering services for vaccine development.

Access press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-vaccine-contract-manufacturing-market

About Grand View Research

For More Information: www.grandviewresearch.com

Global Mobile Imaging Services Market Is Thriving Worldwide 2014 – 2025

The global mobile imaging services market size is expected to reach USD 2.05 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 3.2% over the forecast period. Demand for mobile imaging services is primarily driven by global rise in incidence of chronic diseases such as cancer, cardiovascular diseases, gastrointestinal and endocrinal disorders, and neurological and lung disorders.

Aging increases the risk of diseases such as heart diseases, musculoskeletal disorders, and neural disorders owing to weaker immune system and body strength. These diseases can also arise as a result of factors such as extended lifespan of individuals, increase in consumption of alcohol, smoking, sedentary lifestyle, and unhealthy eating habits.

Some of the companies engaged in mobile imaging services are Cobalt Health, Front Mobile Imaging, Digirad Corporation, InHealth Group Ltd., Alliance HealthCare Services, TridentUSA Health Services, and Shared Medical Services. Mergers and acquisitions, collaborations, and partnerships are among the key strategies adopted by players in the market.

To request a sample copy or view summary of this report:
https://www.grandviewresearch.com/industry-analysis/mobile-imaging-services-market

Further key findings from the study suggest:

Increasing prevalence of chronic diseases and rise in imaging procedures is primarily driving the global market
By product, MRI accounted for the largest market share in 2016 mainly due to growing use of this imaging technique in accident victims and patients suffering from chronic illnesses
The others segment, which includes bone densitometers and stereotactic breast biopsy equipment, will exhibit the fastest growth rate owing to factors such as increasing incidence of osteoporosis and growing geriatric population
North America is dominating the global market, followed by Europe. Adoption of mobile imaging services and exponential growth in remote patient monitoring and telehealth services are prime factors responsible for the growth of these regions
Key players in the market include Cobalt Health, Front Mobile Imaging, Digirad Corporation, InHealth Group Ltd., Alliance HealthCare Services, TridentUSA Health Services, and Shared Medical Services.

Access press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-mobile-imaging-services-market

About Grand View Research

For More Information: www.grandviewresearch.com

Monday, 5 March 2018

Protein Extracts from Single Cell Protein & Other Conventional Sources Market Is Growing At a Rapid Pace - Industry Analysis & Forecast to 2025

The global protein extracts from single cell protein and other conventional sources market size is expected to reach USD 26.3 billion by 2025, according to a new report by Grand View Research, Inc. Registering an 8.4% CAGR during the forecast period, the market is expected to be driven by rising investments in the animal feed industry to cater to rising demand for cattle feed.

India ranks first with respect to cattle inventory, with demand for cattle inventory constantly increasing in U.S. This is driving demand for animal feed and protein extracts from different sources. In U.S., approximately 12.0% of the cattle inventory falls under drought area. This percentage was approximately 73.0% and 26.0% in 2013 and 2008, respectively.

Furthermore, the combination of genetic engineering techniques to produce proteins and attain better expression levels is expected to boost this market. These genetic modifications aid in increasing nutraceutical value of the biomass product either by increasing amino acid composition or by optimization of other biomolecules present in the product. Moreover, there are a number of methods for the removal of ribonucleic acid (RNA) from extracted protein, another factor likely to impact market growth.

To request a sample copy or view summary of this report:
https://www.grandviewresearch.com/industry-analysis/ready-to-drink-tea-and-ready-to-drink-coffee-market

Further key findings from the report suggest:

Market penetration of protein extracts in pharmaceuticals and nutraceuticals is highest in the market and consequently, these segments accounted for a larger share in 2016
Animal feed protein extracts and agricultural protein extracts are anticipated to grow at a similar pace in the coming years owing to rising demand for proteins in these sectors. Traditional protein sources have been inadequate in catering to growing demand
Plant protein sources accounted for the largest share owing to easy availability. However, SCP-based extracts are anticipated to grow at lucrative rate environmental concerns play a strong role in driving the development of novel SCP products
North America accounts for the largest share in the protein extracts market with respect to pharmaceutical applications. Presence of well-established companies engaged in feed production through microbial cell cultivation have attributed to its growth
Ongoing research studies in U.S. regarding use of microbes as an alternative nutrient source is expected to propel the growth of this regional market during the forecast period
Asia Pacific accounted for the largest share in protein extract consumption with regard to animal feed. In recent times, universities and industries in China have been observed to be significantly active in filing patents related to SCP. This is sure to have a positive impact on regional growth
Some of the prominent players in the market are Nutreco; AgriProtein Holdings; ZEN-NOH; KnipBio; BlueBioTech Int. GmbH; Lallemand Inc.; and Marlow Foods Limited.

Access press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-protein-extracts-from-single-cell-protein-other-conventional-sources-market

About Grand View Research

For More Information: www.grandviewresearch.com

Thursday, 1 March 2018

Rapid Increase in Rheumatoid Arthritis Drugs Market - Key Factors, Market Segments Regions and Industry Forecasts Analysis to 2025

The global rheumatoid arthritis therapeutics market size is expected to reach USD 30.4 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.6% during the forecast period. Some of the key trends driving the market are availability of novel biologics, increase in potential clinical pipeline candidates, and rise in aging population. Thus, growing availability and awareness of safer drugs are projected to escalate rheumatoid arthritis drugs market growth.

Rheumatoid arthritis affects approximately 1% of the global population. The condition has different symptoms such as joint pain, swelling, and stiffness, which are generally accompanied by chronic pain and inability to perform daily activities. Over a prolonged period, this disorder can hamper a patient’s mobility and can lead to permanent joint damage. If left untreated, this disorder can lead to mobility impairment and risk of joint replacement.

Growing prevalence of the disease, presence of biologics & biosimilars, and well-defined regulatory guidelines are poised to provide a fillip to the market. According to the Arthritis Foundation, 64% of the population within the age group of 65 is likely to suffer from arthritis in U.S. Increasing awareness regarding disease remittance therapies and rising healthcare expenditure in developed regions are estimated to promote revenue growth.

Current treatment for rheumatoid arthritis includes generic pharmaceuticals such as NSAIDs and corticosteroids along with novel biologics such as JAK inhibitors and IL-6 antagonists, which are widely used in developed countries due to their high effectiveness. New product launches such as Infliximab and Adalimumab biosimilars are anticipated to work in favor of the market. Moreover, Eli Lilly’s Olumiant and AbbVie’s Upadacitinib are expected to cut down chances of disease remittance.

To request a sample copy or view summary of this report:
https://www.grandviewresearch.com/industry-analysis/rheumatoid-arthritis-therapeutics-market

Further key findings from the report suggest:

North America held 56.6% of the market in 2016 due to rising awareness regarding disease treatment, growing geriatric population, and high adoption of biopharmaceuticals for treatment
Due to growing popularity, the biopharmaceuticals segment is projected to exhibit a CAGR of 8.3% during the forecast period
Prescriptions are anticipated to emerge as more reliable and a preferred sales channel over the same period
Asia Pacific is the most promising region, registering a CAGR of 9.5% between 2017 and 2025
Some of the key players in rheumatoid arthritis market are AbbVie; Boehringer Ingelheim GmbH; Novartis AG; Regeneron Pharmaceuticals, Inc.; Pfizer, Inc.; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; UCB S.A.; Johnson & Johnson Services, Inc.; and Amgen, Inc.

Access press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-rheumatoid-arthritis-therapeutics-market

About Grand View Research

For More Information: www.grandviewresearch.com